Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: Data from the CHEST-2 open-label, randomised, long-term extension trial

Gérald Simonneau, Andrea M. D'Armini, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Pavel Jansa, Nick H. Kim, Eckhard Mayer, Tomas Pulido, Chen Wang, Pablo Colorado, Arno Fritsch, Christian Meier, Sylvia Nikkho, Marius M. Hoeper

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: Data from the CHEST-2 open-label, randomised, long-term extension trial'. Together they form a unique fingerprint.

Medicine & Life Sciences